Donald J. Hayden Jr., Director at Theseus Pharmaceuticals, Inc. (THRX), bought 10,000 shares at $5.00 ($50K) on 2022-12-29, disclosed to the SEC on 2023-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 100 | $500 | 1.0% |
| 2 | $5.00 | 9,900 | $50K | 99.0% |
| Total | $5.00 avg | 10,000 | $50K | 100% |
| Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| RGNX | SELL | 2020-01-16 | $1.4M | — | Filing → |
| INSM | SELL | 2019-04-11 | $415K | — | Filing → |